RMD - ResMed Inc. - Strawman: ASX share price, valuation, research and discussion

Reports (7) My Report Forum Investors

Top member reports

Consensus

Jnf17

Company Report

Last edited 5 years ago

Performance (63m)

16.6% pa

Followed by

Straws

Sort by:

Recent

Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.

Become a member

#Bull Case

stale

Jnf17

Last edited 5 years ago

Despite a "miss" on expectations, ResMed continues to be a quality business with great growth possibility and returned a solid quarterly result despite it being weaker than expected.

Should be noted that their legal battle over patents with Fisher & Paykel is a risk.

ResMed Inc.

ResMed Inc.

Set Price Alert for RMD

Place trade